In trading on Friday, shares of Repligen Corp. (Symbol: RGEN) crossed above their 200 day moving average of $149.51, changing hands as high as $152.46 per share. Repligen Corp. shares are ...
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including ...
WALTHAM, Mass., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will ...